(Q39377625)

11 September 2017

title

Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (English)

1 reference

allergic contact dermatitis

11 September 2017

0 references

1 reference

E Gaffal

1

1 reference

11 September 2017

M Cron

series ordinal

2

1 reference

11 September 2017

N Glodde

series ordinal

3

1 reference

11 September 2017

T Tüting

series ordinal

4

1 reference

11 September 2017

publication date

29 July 2013

1 reference

11 September 2017

1 reference

11 September 2017

volume

68

1 reference

11 September 2017

issue

8

1 reference

11 September 2017

page(s)

994-1000

1 reference

Mechanisms of chemical-induced innate immunity in allergic contact dermatitis

11 September 2017

cites work

1 reference

Attenuation of allergic contact dermatitis through the endocannabinoid system

21 January 2018

1 reference

Protective role of palmitoylethanolamide in contact allergic dermatitis

21 January 2018

1 reference

Cannabinoid-based drugs as anti-inflammatory therapeutics

21 January 2018

1 reference

Cannabinoids as novel anti-inflammatory drugs

21 January 2018

1 reference

Cannabinoid system in the skin - a possible target for future therapies in dermatology

21 January 2018

1 reference

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor

21 January 2018

1 reference

The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase.

21 January 2018

1 reference

Keratinocytes in allergic skin diseases.

21 January 2018

1 reference

Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB1/CB2 receptors.

21 January 2018

1 reference

Cannabinoids and the immune system

21 January 2018

1 reference

The effect of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol on T-lymphocyte and B-lymphocyte mitogen responses

21 January 2018

1 reference

The cannabinoid system and cytokine network

21 January 2018

1 reference

Falcarinol is a covalent cannabinoid CB1 receptor antagonist and induces pro-allergic effects in skin

21 January 2018

1 reference

Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis

21 January 2018

1 reference

Nonclassical and endogenous cannabinoids: effects on the ordering of brain membranes.

21 January 2018

1 reference

Roles of transient receptor potential proteins (TRPs) in epidermal keratinocytes

21 January 2018

1 reference

Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1

21 January 2018

1 reference

Non-neuronal expression of transient receptor potential type A1 (TRPA1) in human skin

21 January 2018

1 reference

Evidence for novel cannabinoid receptors

21 January 2018

1 reference

The enigmatic pharmacology of GPR55

21 January 2018

1 reference

Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ALL.12183

1 reference

11 September 2017

1 reference